secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcutis Biotherapeutics, Inc. (ARQT)
CIK:        0001787306
Form:       8-K
Filed at:   2022-06-02T23:59:59+00:00
Accession:  0001787306-22-000038
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Arcutis stockholders elect all three Class II directors and ratify Ernst & Young
--------------------------------------------------------------------------------

- Bhaskar Chaudhuri received 39.76M votes for, 3.83M withheld; Howard Welgus 30.92M for, 12.66M withheld; Sue-Jean Lin 39.09M for, 4.49M withheld.
- Ratification of Ernst & Young as independent auditor for FY 2022: 47.07M for, 48k against, 14k abstain.
- Non-binding advisory vote on executive compensation: 41.01M for, 2.07M against, 502k abstain.
- Advisory vote on frequency of say-on-pay: majority (43.40M votes) favored one year.
- About 51.4M shares outstanding and entitled to vote; broker non-votes were 3.55M on director and say-on-pay proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787306/000178730622000038/0001787306-22-000038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787306/000178730622000038/arqt-20220601.htm
  HTML page:      https://secwatch.observer/filing/0001787306-22-000038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer